GENB
Common StockGenerate Biomedicines, Inc.
Healthcare
Reported Shares
62.7M
Position Mix
No options reported
Reported Value
$941.4M
Portfolio Weight
48.14%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$2.0B
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
GENB
Common StockGenerate Biomedicines, Inc.
Reported Shares
62.7M
Position Mix
No options reported
Reported Value
$941.4M
Portfolio Weight
48.14%
MRNA
Common StockModerna, Inc.
Reported Shares
4.6M
Position Mix
No options reported
Reported Value
$892.0M
Portfolio Weight
45.62%
SANA
Common StockSana Biotechnology, Inc.
Reported Shares
25M
Position Mix
No options reported
Reported Value
$72.9M
Portfolio Weight
3.73%
FHTX
Common StockFoghorn Therapeutics Inc.
Reported Shares
12.7M
Position Mix
No options reported
Reported Value
$45.2M
Portfolio Weight
2.31%
MCRB
Common StockSeres Therapeutics, Inc.
Reported Shares
1.2M
Position Mix
No options reported
Reported Value
$3.9M
Portfolio Weight
0.20%